Endpoint Clinical

We started in 2009 in Raleigh, NC, and now have offices across the US, EU, and Asia.

We provide Randomization and Trial Supply Management (RTSM) solutions for clinical trials in the pharmaceutical manufacturing industry. Our services include IVR/IWR for clinical trials, IXRS, Inventory Management, clinical supply management, and IRT.

We offer two main solutions: PULSE, a dynamic and customizable RTSM, and Elosity, a flexible, next-generation RTSM. We provide continuous support to anticipate and resolve issues, reducing friction and risk in trial operations.

We’ve supported over 2,000 studies at more than 90,000 sites in over 90 countries, involving over 650,000 patients. Nagaraja Srivatsan is our Chief Executive Officer.

Our mission is to improve clinical trials with purpose-built RTSM. We aim to deliver innovative, high-quality RTSM solutions that help bring lifesaving treatments to patients faster.

We foster a culture of excellence, accountability, and collaboration.

With 501-1000 employees, we are dedicated to solving challenging problems in randomization and trial supply management (RTSM).

We focus on recruiting talent, supporting growth, and creating a workplace where everyone can thrive. We value diversity and ensure equal opportunities in our hiring process.

We maintain a collaborative culture across our global locations. We use technology to enable productive work, frequent communication, and engaging activities.

Built In recognized us as a Top 100 Midsize Place to Work from 2021 to 2025.

We offer a range of employee benefits, including Medical, Dental, Vision, Life, STD/LTD, 401(K), Paid time off (PTO) or Flexible time off (FTO), and company bonuses.